Is There An Opportunity With ProQR Therapeutics N.V.'s (NASDAQ:PRQR) 37% Undervaluation?

Yahoo FinanceDec 20, 2024 20:19

ProQR Therapeutics N.V. (NASDAQ:PRQR) Shares May Have Slumped 29% But Getting In Cheap Is Still Unlikely

Simply Wall StDec 14, 2024 20:31

Chardan Capital Maintains ProQR Therapeutics(PRQR.US) With Buy Rating, Maintains Target Price $4

Futu NewsDec 12, 2024 21:31 · Ratings

ProQR Therapeutics Is Maintained at Buy by Chardan Capital

Dow JonesDec 12, 2024 20:59 · Ratings

H.C. Wainwright Maintains ProQR Therapeutics(PRQR.US) With Buy Rating, Maintains Target Price $10

Futu NewsDec 12, 2024 20:31 · Ratings

ProQR Therapeutics Price Target Maintained With a $10.00/Share by HC Wainwright & Co.

Dow JonesDec 12, 2024 20:21 · Ratings